Dr. Yaron Daniely, PhD, head of aMoon Alpha, an internal section of aMoon, a healthtech and life sciences venture fund based in Israel, discusses his work at aMoon Alpha.
Dr. Yaron Daniely is the Head of aMoon Alpha, an internal aMoon unit charged with maximizing the fund’s unique scale and talent capabilities to achieve excess returns through portfolio success. Before joining aMoon, Dr. Daniely was President & CEO of Yissum, the Hebrew University’s renowned Technology Transfer Company, and the co-chairperson of the Israel Technology Transfer Network – ITTN. Before joining Yissum in 2017, he served for eight years as President, CEO and Chairman of Alcobra Ltd (NASDAQ: ADHD). Prior to his appointment at Alcobra, Yaron held a number of leadership positions, including President and CEO of NanoCyte Inc., General Manager and VP of Business Development at Gamida Cell Ltd (NASDAQ:GMDA), and co-founder and Director of Bioblast Ltd. (NASADQ:ORPN).Yaron earned his PhD from the Sackler Institute of Graduate Biomedical Sciences at the NYU School of Medicine. Following his doctoral program, Yaron served as a Visiting Fellow at the NIH, and as an American Cancer Society Postdoctoral Fellow in the Department of Molecular Cell Biology at The Weizmann Institute for Science in Israel. Yaron also holds an MBA degree from the Technion-Israel Institute of Technology.